The Health Sciences Institute is intended to provide cutting-edge health information.
Nothing on this site should be interpreted as personal medical advice. Always consult with your doctor before changing anything related to your healthcare.

The fix is in

“This bill will save lives and restore America’s confidence in the use of dietary supplements.”

Those were the words of Senator Dick Durbin last March when he introduced Senate Bill 722 (S. 722) titled the “Dietary Supplement Safety Act of 2003.”

What Senator Durbin didn’t mention is that S. 722 will broadly expand the FDA’s authority to control the dietary supplement market.

Simply put: these regulations will seriously inhibit your current freedom to make your own health decisions. But there is something you can do to help prevent this from happening.

Lives left behind

First let’s talk about saving lives.

There are many hundreds of deaths each year associated with aspirin and acetaminophen. (By some estimates, aspirin-related deaths alone number more than 1,000 per year.) These pain killers are manufactured by many companies, but the major players are Bayer (the maker of Bayer Aspirin, of course), and Johnson & Johnson (the maker of Tylenol) – two of the largest drug companies in the world. They both have deep pockets to fuel very aggressive lobbying efforts in Washington.

So don’t expect to hear any senators calling for a ban of aspirin or acetaminophen. (Deaths? What deaths?)

Ephedra, on the other hand, is a sitting duck.

S. 722 doesn’t mention any specific supplements, but Senator Durbin’s press release uses the recent controversy surrounding ephedra to promote the fear of supplements. Senator Durbin states that 117 deaths have been attributed to ephedra. (That’s 117 deaths TOTAL – not 117 per year.) What he doesn’t mention is that almost all of these deaths involved a synthetic form of ephedra – a drug, in other words – called ephedrine, in which the active agent of ephedra is boosted to levels that can be dangerous if not taken as directed.

When used properly, ephedrine is a strong weapon in the battle to control your weight. And, more important, the actual herb ephedra is an effective treatment for asthma. If ephedra is banned, the main winners will be pharmaceutical companies that make asthma drugs.

So when you hear lawmakers talking about “saving lives,” and “protecting the public,” be aware that their targets are very selective when it comes to the products they want to see banned.

Get out your handkerchiefs

Senator Durbin wants you to think that the poor folks over at the FDA are working with their hands tied behind their backs. His press release states, “The burden is currently placed on the U.S. Food & Drug Administration (FDA) to prove that they are unsafe before the agency can take any action against dangerous dietary supplements.” And according to Durbin, “this places an unreasonably high hurdle in the path of effective agency action.”

Senator Durbin knows better. The FDA currently has the power to pull any product off the market that it deems to be unsafe.

The inquisition

Under S. 722, the FDA will have the power to remove an entire class of supplements from the market if there is even a single serious adverse reaction complaint filed. This will be the case even if the complaint is filed by someone who has used the supplement in contradiction to the instructions and warnings of the manufacturer.

In such an instance, the manufacturer will be required to demonstrate the safety of the supplement. This process is expected to put a heavy financial burden on accused manufacturers – heavy enough to drive some out of business. For those supplements that do reach the evaluation stage, the FDA will set the standards for the evaluations and then determine if the standards are met. In effect, the FDA will act as prosecutor, judge, and jury, while accused manufacturers foot the bill against a stacked deck.

That’s like asking a death row inmate to pay an electric bill in advance for his electrocution.

Chipping away at freedom

Will S. 722 save lives? I seriously doubt it. Behind this bill there’s a naive idea that a law to strengthen regulations can make everything all right. And yet the current regulations that promise safety for prescription drug users somehow let many thousands of lives slip through the cracks every year. Increased regulations can’t guarantee safety, but they do guarantee greater power for regulators.

And when that power is increased, what then? Here’s a comment from a recent e-mail I received from HSI Panelist Allan Spreen, M.D.: “I’m convinced the Dietary Supplement Safety Act is merely a stepping stone to complete control. The FDA has been very upset about the passage of DSHEA (the Dietary Supplement Health and Education Act (DSHEA) of 1994 – specifically designed to help protect the supplement industry from unnecessary constraints). I think the FDA will piecemeal DSHEA away as fast as possible, if possible (and I believe it is).”

S. 722 may come before the Senate for a vote before the end of this month. And although it has good support, its passage is not a foregone conclusion. I strongly urge you to take a moment to send a brief letter or e-mail to your state Senators. (You can easily find Congressional addresses and e-mail addresses at congress.org just by entering your zip code.)

Tell your Senators that you oppose S. 722 (the “Dietary Supplement Safety Act of 2003”), which will limit your freedom to make your own health care choices with the responsible use of dietary supplements. Tell them that S. 722 unnecessarily expands the authority of the Food and Drug Administration, while offering no more protection for consumers than is already granted under the Dietary Supplement Health and Education Act (DSHEA) of 1994.

Think of S. 722 is a staging area from which the FDA will prepare to slowly but surely dismantle the dietary supplement freedom that we’ve enjoyed for almost a decade under DSHEA. The first line of defense is to convince our senators that this act is unnecessary and will do more harm than good.

Please share this e-Alert with a friend and help get the word out about S. 722.

To Your Good Health,

Jenny Thompson
Health Sciences Institute

Sources:

“Dietary Supplement Safety Act of 2003” Senate Bill 722, 3/26/03, congress.org
“Durbin Moves to Prevent Sale of Dangerous Dietary Supplements like Ephedra” Dick Durbin Press Release, 3/26/03, durbin.senate.gov

“FDA Moving to Dismantle DSHEA” Smart Publications, 4/25/03, smart-publications.com

“An Urgent Call to Action: Your Right to Use Nutritional Supplements is in Jeopardy” Julian Whitaker, M.D., 7/17/03, drwhitaker.com

“Toxicity, Acetaminophen” Susan E. Farrell, M.D., emedicine.com

Get a free copy of 5 Household Items that Cause Cancer

By texting HSI to 844-539-1128, you are providing your electronic signature expressly consenting to be called and texted (including by prerecorded messages, using an autodialer, and/or automated means) with alerts, stories, reports, and marketing communications from Institute of Health Sciences, LLC. and its authorized representatives at the phone number you provide, including landlines and wireless numbers, even if the phone number is on a corporate, state or national Do Not Call list. You also consent and unconditionally agree to our Privacy Policy and Terms of Use, including the arbitration provision and class action waiver contained therein. Msg&data rates may apply. 15 Msgs/Month. You are not required to agree to this as a condition of making a purchase.

Terms & Conditions

The following Terms and Conditions apply to your use of the website located at hsionline.com (the “website”) and any text messages that you send to or receive from the Institute of Health Sciences, L.L.C. These Terms and Conditions constitute a binding agreement (“Agreement”) between you (“you”) Institute of Health Sciences, L.L.C (“we”, “us”, etc.)  Please read these terms carefully. 

By providing your telephone number to us, texting us a short code listed on the website, or otherwise indicate your agreement to these Terms and Conditions, you are agreeing to the mandatory arbitration provision and class action waiver below. 

ARBITRATION IS MANDATORY AND THE EXCLUSIVE REMEDY FOR ANY AND ALL DISPUTES RELATED TO THIS WEBSITE, THIS AGREEMENT, AND ANY TELEPHONE CALLS, EMAILS, OR TEXT MESSAGES THAT YOU RECEIVE FROM OR ON BEHALF OF US, UNLESS SPECIFIED BELOW OR UNLESS YOU OPT-OUT.

Text Messaging and Telemarketing Terms and Conditions

When you provide your telephone number on this website or send a text message to us with or from a short-code, you agree to receive alerts and communications, and marketing messages including those sent via automated telephone dialing system, text messages, SMS, MMS, and picture messages from Institute of Health Sciences, L.L.C at the phone number you provide on this website or the phone number from which you text the short code, including on landlines and wireless numbers, even if the phone number is on a corporate, state or national Do Not Call list. You also agree to the mandatory arbitration provision and class action waiver below. Your consent is not required to purchase goods or services. Message & data rates may apply.

You may opt-out at any time by texting the word STOP to the telephone number from which you receive the text messages.  Call 1-888-213-0764 to learn more.  By providing your telephone number, you agree to notify us of any changes to your telephone number and update your account us to reflect this change. Your carrier may charge you for text messages and telephone calls that you receive, or may prohibit or restrict certain mobile features, and certain mobile features may be incompatible with your carrier or mobile device. Contact your carrier with questions regarding these issues.

Dispute Resolution by Binding Arbitration and Class Action Waiver

Any dispute relating in any way to telephone calls, emails, or text messages that you receive from or on behalf of Institute of Health Sciences, L.L.C this website, or this Agreement (collectively “Disputes”) shall be submitted to confidential arbitration and shall be governed exclusively by the laws of the State of Maryland, excluding its conflict of law provisions.  For the avoidance of doubt, all claims arising under the Telephone Consumer Protection Act and state telemarketing laws shall be considered “Disputes” that are subject to resolution by binding individual, confidential arbitration.

If a Dispute arises under this Agreement, you agree to first contact us at 1-888-213-0764 or help@hsionline.com. Before formally submitting a Dispute to arbitration, you and we may choose to informally resolve the Dispute.  If any Dispute cannot be resolved informally, you agree that any and all Disputes, including the validity of this arbitration clause and class action waiver, shall be submitted to final and binding arbitration before a single arbitrator of the American Arbitration Association (“AAA”) in a location convenient to you or telephonically. Either you or we may commence the arbitration process by submitting a written demand for arbitration with the AAA, and providing a copy to the other party.  The arbitration will be conducted in accordance with the provisions of the AAA’s Commercial Dispute Resolutions Procedures, Supplementary Procedures for Consumer-Related Disputes, in effect at the time of submission of the demand for arbitration.  Except as may be required by law as determined by the arbitrator, no party or arbitrator may disclose the existence, content or results of any arbitration hereunder without the prior written consent of both parties. Institute of Health Sciences, L.L.C will pay all of the filing costs.  Without limiting the foregoing, YOU EXPRESSLY AGREE TO SUBMIT TO ARBITRATION ALL DISPUTES RELATING TO ANY TEXT MESSAGES OR TELEPHONE CALLS YOU RECEIVE FROM OR ON BEHALF OF US OR ANY ENTITY WITH WHOM WE MAY SHARE YOUR TELEPHONE NUMBER.  Further, we both agree that all entities with whom we share your telephone numbers shall be third party beneficiaries of this Agreement to Arbitrate Disputes, and that those entities have the same rights as Institute of Health Sciences, L.L.C to enforce this arbitration provision.

Notwithstanding the foregoing, the following shall not be subject to arbitration and may be adjudicated only in the state and federal courts of Maryland: (i) any dispute, controversy, or claim relating to or contesting the validity of our or one of our family company’s intellectual property rights and proprietary rights, including without limitation, patents, trademarks, service marks, copyrights, or trade secrets; (ii) an action by us for temporary or preliminary injunctive relief, whether prohibitive or mandatory, or other provisional relief; (iii) any legal action by us against a non-consumer; or (iv) interactions with governmental and regulatory authorities.  You expressly agree to refrain from bringing or joining any claims in any representative or class-wide capacity, including but not limited to bringing or joining any claims in any class action or any class-wide arbitration.

The arbitrator’s award shall be binding and may be entered as a judgment in any court of competent jurisdiction. To the fullest extent permitted by applicable law, no arbitration under this Agreement may be joined to an arbitration involving any other party subject to this Agreement, whether through a class action, private attorney general proceeding, class arbitration proceedings or otherwise.

YOU UNDERSTAND THAT YOU WOULD HAVE HAD A RIGHT TO LITIGATE IN A COURT, TO HAVE A JUDGE OR JURY DECIDE YOUR CASE AND TO BE PARTY TO A CLASS OR REPRESENTATIVE ACTION.  HOWEVER, YOU UNDERSTAND AND AGREE TO HAVE ANY CLAIMS DECIDED INDIVIDUALLY AND ONLY THROUGH ARBITRATION.  You shall have thirty (30) days from the earliest of the date that you visit the website, the date you submit information to us through the website, or the date that you send a text message to us, to opt out of this arbitration agreement, by contacting us by email at help@hsionline.com or by mail Health Sciences Institute, PO Box 913, Frederick, MD 21705-0913. If you do not opt out by the earliest of the date that you visit the website, the date you submit information to us through the website, or the date that you send a text message to us, then you are not eligible to opt out of this arbitration agreement.

Electronic Signatures

All information communicated on the website is considered an electronic communication.  When you communicate with us through or on the website, by text message or telephone, or via other forms of electronic media, such as e-mail, you are communicating with us electronically.  You agree that we may communicate electronically with you and that such communications, as well as notices, disclosures, agreements, and other communications that we provide to you electronically, are equivalent to communications in writing and shall have the same force and effect as if they were in writing and signed by the party sending the communication.

You further acknowledge and agree that by clicking on a button labeled “ORDER NOW”, “SUBMIT”, “I ACCEPT”, “I AGREE”, “YES”, by texting a short code to us in response to a request on this website, or by clicking or similar links or buttons, you are submitting a legally binding electronic signature and are entering into a legally binding contract.  You acknowledge that your electronic submissions constitute your agreement and intent to be bound by this Agreement.  Pursuant to any applicable statutes, regulations, rules, ordinances or other laws, including without limitation the United States Electronic Signatures in Global and National Commerce Act, P.L. 106-229 (the “E-Sign Act”) or other similar statutes, YOU HEREBY AGREE TO THE USE OF ELECTRONIC SIGNATURES, CONTRACTS, ORDERS AND OTHER RECORDS AND TO ELECTRONIC DELIVERY OF NOTICES, POLICIES AND RECORDS OF TRANSACTIONS INITIATED OR COMPLETED THROUGH THE WEBSITE.  Furthermore, you hereby waive any rights or requirements under any statutes, regulations, rules, ordinances or other laws in any jurisdiction which require an original signature, delivery or retention of non-electronic records, or to payments or the granting of credits by other than electronic means You may receive a physical paper copy of this contract by contacting us at help@hsionline.com.

Privacy Policy

Please read our Privacy Policy, which is incorporated herein by reference.  In the event of any conflict between these Terms and Conditions and the Privacy Policy, these Terms shall control.

Contact Us

You may contact us by telephone at 1-888-213-0764 or by email at help@hsionline.com.